Colony Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Colony Group LLC holds 3,747 shares of REGN stock, worth $2.71 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,747

Previous 2,659 40.92%

Holding current value

$2.71 Million

Previous $1.91 Million 61.38%

% of portfolio

0.05%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $753,385 - $918,674	1,088 Added 40.92%	3,747 $3.08 Million
Q2 2023 Aug 15, 2023	SELL	$700.03 - $830.35 $947,840 - $1.12 Million	-1,354 Reduced 33.74%	2,659 $1.91 Million
Q1 2023 May 16, 2023	SELL	$680.49 - $826.97 $59,883 - $72,773	-88 Reduced 2.15%	4,013 $3.3 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.3 Million - $1.41 Million	1,845 Added 81.78%	4,101 $2.96 Million
Q3 2022 Nov 15, 2022	SELL	$573.97 - $724.32 $140,048 - $176,734	-244 Reduced 9.76%	2,256 $1.55 Million
Q2 2022 Aug 16, 2022	SELL	$548.35 - $738.84 $1.03 Million - $1.39 Million	-1,886 Reduced 43.0%	2,500 $1.48 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $821,265 - $963,833	1,380 Added 45.91%	4,386 $3.06 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $2.27 Million - $2.8 Million	-4,170 Reduced 58.11%	3,006 $1.9 Million
Q3 2021 Nov 17, 2021	BUY	$574.03 - $680.96 $1.26 Million - $1.49 Million	2,188 Added 43.87%	7,176 $4.34 Million
Q2 2021 Aug 18, 2021	BUY	$472.8 - $558.54 $8,510 - $10,053	18 Added 0.36%	4,988 $2.79 Million
Q1 2021 May 21, 2021	BUY	$446.73 - $548.2 $344,428 - $422,662	771 Added 18.36%	4,970 $2.35 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $266,891 - $339,252	558 Added 15.33%	4,199 $2.03 Million
Q3 2020 Nov 17, 2020	BUY	$544.75 - $658.21 $992,534 - $1.2 Million	1,822 Added 100.16%	3,641 $2.04 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $5,919 - $7,727	12 Added 0.66%	1,819 $1.13 Million
Q1 2020 May 18, 2020	SELL	$336.18 - $494.43 $46,056 - $67,736	-137 Reduced 7.05%	1,807 $882,000
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $2.21 Million - $3.03 Million	-8,056 Reduced 80.56%	1,944 $730,000
Q3 2019 Nov 26, 2019	BUY	$273.46 - $318.39 $2.73 Million - $3.18 Million	10,000 New	10,000 $2,000

Others Institutions Holding REGN

# of Institutions

1,494

Shares Held

83.1M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account